Molecule intelOpportunity: ModerateEssential

Propofol

28 brands · 22 companies · product forms

ATC: N01AX10

Opportunity snapshot

Launch attractiveness
44
Market saturation
57
Price room
100
Regulatory risk
0
28
brands
22
companies
Rs 2,845.82
median price
25
price points
7.41x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 11%

Price room

Across observed sources and strengths
CheapestRs 465.96
MedianRs 2,845.82
Most expensiveRs 3,452.67
Spread7.41×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 7.41x across 25 trusted points (Rs 465.96-3452.67). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Propofol — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(43) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

22 canonical companies and 28 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 7.41x across 25 trusted points (Rs 465.96-3452.67). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.